Essential hypertension: biochemical analysis--selective treatment
Bühler, R.; Laragh, J.H.
Schweizerische Rundschau für Medizin Praxis 62(16): 489-491
1973
ISSN/ISBN: 1013-2058 PMID: 4349069 Document Number: 65960
Document emailed within 1 workday
Related Documents
Nelson, G.I.; Hussain, M.; Forsyth, D.; Wilson, J.; Silke, B.; Taylor, S.H. 1984: Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension Journal of Cardiovascular Pharmacology 6(1): 176-181Denker, P.S.; Pollock, V.E. 1992: Fasting serum insulin levels in essential hypertension. a meta-analysis Archives of Internal Medicine 152(8): 1649-1651
Stott, D.J.; Ball, S.G. 1986: Treatment of essential hypertension British Journal of Hospital Medicine 36(4): 261
Ye, W-jing.; Zheng, L.; Wang, Z-hua.; Chen, H-huan. 2013: Meta analysis on the association of CYP11B2 gene polymorphism and essential hypertension in Chinese Han population Zhonghua Xin Xue Guan Bing Za Zhi 41(9): 795-799
Dosh, S.A. 2002: The treatment of adults with essential hypertension Journal of Family Practice 51(1): 74-80
Salgueiro Rodríguez, M.; Pérez Pombo, S.; Beiras García, E. 1981: Metoprolol in the treatment of essential hypertension Medicina Clinica 76(3): 121-124
Minushkina, L.O.; Sidorenko, B.A. 2003: Metoprolol in the treatment of essential hypertension Kardiologiia 43(11): 102-105
Kakhnovskiĭ, I.M.; Sivkov, S.I.; Gavrilova, E.N.; Belaia, O.L.; Sivkov, A.S.; Markova, Z.S.; Markov, I.E.; Gaĭdamakina, N.E. 1998: Prestarium treatment of essential hypertension Klinicheskaia Meditsina 76(9): 52-54
Sharma, P.L.; Pandhi, P. 1985: Progress in the treatment of essential hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 23 Suppl. 1: S54-S61
Gerc, V.; Numić, N. 1984: Modern treatment of essential hypertension Medicinski Arhiv 38(5): 233-238
Milei, J.; Lemus, J.; Bernardiner, E. 1986: Ketanserin in the treatment of essential hypertension. a double-blind study against metoprolol and a further long-term open treatment Acta Cardiologica 41(6): 427-441
Oshima, T.; Matsuura, H.; Kido, K.; Matsumoto, K.; Shingu, T.; Otsuki, T.; Inoue, I.; Kajiyama, G. 1989: Factors determining sodium chloride sensitivity of patients with essential hypertension: evaluation by multivariate analysis Journal of Hypertension 7(3): 223-227
Garnier, L.F. 1988: Essential arterial hypertension. from notion to treatment Annales de Cardiologie et d'Angeiologie 37(7): 371-380
Ghiuru, R.; Rezuş, C.; Ambăruş, V.; Ionescu, S.; Cosovanu, A. 2001: Nebivolol treatment in essential arterial hypertension Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 105(4): 756-759
Paladini, G.; Sgoifo, E. 1980: Dioodobufenine in the treatment of essential arterial hypertension Minerva Cardioangiologica 28(5): 303-308
Dvorák, I.; Dvorák, M.; Blaha, M.; Kubesová, H.; Havlát, F.; Nĕmcová, H. 1984: Experience with endralazine in the treatment of essential hypertension Vnitrni Lekarstvi 30(1): 42-47
Pérez-Grovas, H.; Fernández, M.; Arriaga, J.; Herrera-Acosta, J. 1986: Enalapril in the treatment of essential arterial hypertension Archivos del Instituto de Cardiologia de Mexico 56(5): 379-390
Staessen, J.; Fagard, R.; Fiocchi, R.; Lijnen, P.; M'Buyamba-Kabangu, J.R.; Amery, A. 1986: Chronic treatment with tibalosine in essential hypertension Archives Internationales de Pharmacodynamie et de Therapie 279(1): 162-176
Kennedy, S. 2006: Essential hypertension 2: treatment and monitoring update Community Practitioner: the Journal of the Community Practitioners' and Health Visitors' Association 79(2): 64-66
Hilleman, D.E.; Mohiuddin, S.M.; Lucas, B.D.; Stading, J.A.; Stoysich, A.M.; Ryschon, K. 1994: Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension Clinical Therapeutics 16(1): 88